Nelson Advisors European Healthcare Technology Predictions 2027: What can Founders, Investors and Providers expect in 2027?

If 2025 was the year European HealthTech discovered artificial intelligence, and 2026 the year the market learned to price it, then 2027 will be the year the sector is forced to prove it. The froth has gone. What remains is a market that is smaller in deal count, larger in deal size and far more discriminating about what it funds, buys and deploys. Q1 2026 told the story in miniature: European digital health venture funding fell 44% year-on-year to $1.2 billion across just 67 deals, yet average round sizes climbed 8% to over $21 million. Fewer bets, bigger cheques, higher expectations.
  
2027 arrives with three structural forces converging at once. The EU AI Act's high-risk obligations begin to bite in earnest, with enforcement for standalone high-risk AI systems landing in December 2027. The European Health Data Space (EHDS) reaches its first major milestone in March 2027, when the key implementing acts are published and the secondary-use framework starts taking concrete shape. A wall of private capital, private equity dry powder, strategics flush from the GLP-1 boom and a cautiously reopening IPO window, is looking for somewhere to land in a sector where the number of genuinely scaled, profitable European assets remains stubbornly small.
  
For founders, investors and providers, 2027 will not be a year of new narratives. It will be a year of execution against the narratives already in place.

Below are our ten predictions for how that plays out.

https://www.healthcare.digital/single-post/nelson-advisors-european-healthcare-technology-predictions-2027-what-can-founders-investors-and-pr